TY  - JOUR 
AU  - Anguita-Ruiz, A.
AU  - Pastor-Villaescusa, B.
AU  - Leis Trabazo, María Rosaura
AU  - Bueno, G.
AU  - Hoyos, R.
AU  - Vázquez Cobela, Rocio
AU  - Latorre-Millán, M.
AU  - Cañete, M. D.
AU  - Caballero-Villarraso, J.
AU  - Gil, Á
AU  - Cañete, R.
AU  - Aguilera, C. M.
PY  - 2019
SN  - 2077-0383
UR  - http://hdl.handle.net/20.500.11940/15369
AB  - Metformin is a first-line oral antidiabetic agent that has shown additional effects in treating obesity and metabolic syndrome. Inter-individual variability in metformin response could be partially explained by the genetic component. Here, we aimed to...
LA  - eng
TI  - Common Variants in 22 Genes Regulate Response to Metformin Intervention in Children with Obesity: A Pharmacogenetic Study of a Randomized Controlled Trial
DO  - 10.3390/jcm8091471
T2  - Journal of Clinical Medicine
M2  - e1471
KW  - CHUS
VL  - 8
ER  -